Successful treatment of pediatric post-liver transplant kaposi`s sarcoma with paclitaxel

Hilal Susam Şen, Belen Terlemez Ateş, Pınar Yılmazbaş, Süheyla Ocak, Hale Kırımlıoğlu, Selim Gökçe, Koray Acarlı
2020 Turkish Journal of Pediatrics  
Kaposi's sarcoma (KS) is a complication of immunosuppressive therapy for transplant recipients. Unlike adult recipients, KS in pediatric organ transplantation is quite rare. Treatment is usually withdrawal of immunosuppression; non-responders often receive chemotherapy. We have reported a child with post-liver transplant visceral KS which has progressed despite withdrawal of immunosuppressive therapy, who has been treated with Paclitaxel for three weeks. KS has regressed completely after four
more » ... cles of Paclitaxel. Paclitaxel should be considered as an effective first line treatment option for patients with posttransplant KS.
doi:10.24953/turkjped.2020.05.020 pmid:33108091 fatcat:kg367vnorjdcbhiphwnkf3miqa